000			02319 a2200709 4500
005			20250513193845.0
264		0	_c19991027
008			199910s 0 0 eng d
022			_a0098-7484
024	7		_a10.1001/jama.282.14.1335 _2doi
040			_aNLM _beng _cNLM
100	1		_aRowlings, P A
245	0	0	_aFactors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. _h[electronic resource]
260			_bJAMA _cOct 1999
300			_a1335-43 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBone Marrow Transplantation
650	0	4	_aBreast Neoplasms _xmortality
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aDisease Progression
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Metastasis
650	0	4	_aProportional Hazards Models
650	0	4	_aReceptors, Estrogen
650	0	4	_aRisk
650	0	4	_aSurvival Analysis
650	0	4	_aTamoxifen _xtherapeutic use
650	0	4	_aTransplantation, Autologous
650	0	4	_aTreatment Failure
700	1		_aWilliams, S F
700	1		_aAntman, K H
700	1		_aFields, K K
700	1		_aFay, J W
700	1		_aReed, E
700	1		_aPelz, C J
700	1		_aKlein, J P
700	1		_aSobocinski, K A
700	1		_aKennedy, M J
700	1		_aFreytes, C O
700	1		_aMcCarthy, P L
700	1		_aHerzig, R H
700	1		_aStadtmauer, E A
700	1		_aLazarus, H M
700	1		_aPecora, A L
700	1		_aBitran, J D
700	1		_aWolff, S N
700	1		_aGale, R P
700	1		_aArmitage, J O
700	1		_aVaughan, W P
700	1		_aSpitzer, G
700	1		_aHorowitz, M M
773	0		_tJAMA _gvol. 282 _gno. 14 _gp. 1335-43
856	4	0	_uhttps://doi.org/10.1001/jama.282.14.1335 _zAvailable from publisher's website
999			_c10484113 _d10484113